Company page

Biomarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc. is a public company traded under the ticker BMRN in the American market. With a market capitalization of approximately $11.4 billion, the company focuses on developing innovative biopharmaceuticals for serious diseases and medical conditions. Biomarin is known for its commitment to improving the lives of patients through advanced therapies.